Recent Quarter Total Invested
$281.20 M
Recent Quarter Institutional Ownership Percentage
88.45%
Total Invested of Last Quarter
$474.19 M
Ownership Percentage of Last Quarter
84.83%
C4 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 08/14/2024 | 6.88 M | $31.79 M | 89.30% | 10.00% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 4.88 M | $22.54 M | 0.00% | 7.09% |
| WASATCH ADVISORS LP | 08/14/2024 | 4.85 M | $22.39 M | 11.98% | 7.04% |
| BLACKROCK INC. | 08/13/2024 | 4.55 M | $21.03 M | 402.93% | 6.61% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 4.05 M | $18.72 M | 64.78% | 5.89% |
| VANGUARD GROUP INC | 08/13/2024 | 3.56 M | $16.43 M | 21.80% | 5.17% |
| COMMODORE CAPITAL LP | 08/14/2024 | 3.41 M | $15.76 M | 0.00% | 4.96% |
| STATE STREET CORP | 08/14/2024 | 2.99 M | $13.84 M | -58.13% | 4.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 1.94 M | $8.94 M | -20.50% | 2.81% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.77 M | $8.17 M | -4.67% | 2.57% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.51 M | $6.99 M | 100.00% | 2.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 1.44 M | $6.67 M | 0.48% | 2.10% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 1.39 M | $6.43 M | 6.07% | 2.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.36 M | $6.29 M | 166.94% | 1.98% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 1.31 M | $6.04 M | 11.60% | 1.90% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2024 | 1.28 M | $5.90 M | 0.00% | 1.86% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2024 | 1.24 M | $5.75 M | -3.68% | 1.81% |
| MORGAN STANLEY | 08/14/2024 | 1.14 M | $5.26 M | 121.31% | 1.65% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 1.11 M | $5.14 M | -2.65% | 1.62% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 737,835 | $3.41 M | -42.41% | 1.07% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 619,112 | $2.86 M | -2.05% | 0.90% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 560,959 | $2.59 M | -26.66% | 0.82% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 509,406 | $2.35 M | -11.43% | 0.74% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 488,958 | $2.26 M | 82.84% | 0.71% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 431,013 | $1.99 M | 100.00% | 0.63% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 405,885 | $1.88 M | 100.00% | 0.59% |
| UBS GROUP AG | 08/14/2024 | 404,118 | $1.87 M | -41.99% | 0.59% |
| CITADEL ADVISORS LLC | 08/14/2024 | 373,657 | $1.73 M | 11.70% | 0.54% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 356,212 | $1.65 M | -28.26% | 0.52% |
| ATOM INVESTORS LP | 08/14/2024 | 332,620 | $1.54 M | 5.18% | 0.48% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 278,580 | $1.29 M | -69.27% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 260,900 | $1.21 M | -28.83% | 0.38% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 258,426 | $1.19 M | -33.43% | 0.38% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 235,200 | $1.09 M | -42.04% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 229,345 | $1.06 M | 16.35% | 0.33% |
| JUMP FINANCIAL, LLC | 08/14/2024 | 223,200 | $1.03 M | 91.58% | 0.32% |
| CAPITAL FUND MANAGEMENT S.A. | 08/13/2024 | 220,517 | $1.02 M | 187.17% | 0.32% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 200,000 | $924,000 | 100.00% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 190,761 | $881,318 | 100.00% | 0.28% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 185,738 | $858,110 | -77.72% | 0.27% |
| NORTHERN TRUST CORP | 08/14/2024 | 179,573 | $829,627 | 65.23% | 0.26% |
| BARCLAYS PLC | 08/14/2024 | 175,911 | $812,000 | 231.33% | 0.26% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/19/2024 | 142,832 | $659,884 | 100.00% | 0.21% |
| JANE STREET GROUP, LLC | 08/15/2024 | 131,866 | $609,221 | 143.68% | 0.19% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 08/15/2024 | 129,801 | $599,681 | 152.70% | 0.19% |
| MARINER, LLC | 08/13/2024 | 127,879 | $590,801 | -0.12% | 0.19% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 118,473 | $547,345 | -47.23% | 0.17% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 113,436 | $524,000 | 415.78% | 0.16% |
| ARETE WEALTH ADVISORS, LLC | 08/14/2024 | 111,300 | $514,000 | 30.63% | 0.16% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 110,075 | $508,547 | 23.89% | 0.16% |
C4 Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CCCC shares?
During the previous two years, 143 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 6.88 M
RA CAPITAL MANAGEMENT, L.P.: 4.88 M
WASATCH ADVISORS LP: 4.85 M
BlackRock Inc.: 4.55 M
Soleus Capital Management, L.P.: 4.05 M
VANGUARD GROUP INC: 3.56 M
-
What percentage of C4 Therapeutics, Inc. stock is owned by institutional investors?
88.45% of C4 Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CCCC ?
Institutional investors have bought a total of 61.65 M shares in the last 24 months. This purchase volume represents approximately $351.39 M in transactions.